READ HERE for an update on Aetna.

Scott T. Tagawa, M.D., MS, FACP, FASCO

Medical Oncology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

After developing an interest in fighting cancer in medical school, I was fortunate to work with and learn from the leadership field of genitourinary oncology during internship, residency, and fellowship training. I feel fortunate to have joined the faculty at Weill Cornell to work with renowned mentors and colleagues in both medical oncology and urology. Together I am confident we will make progress towards increasing the cure rate and decreasing suffering from these diseases.

Biographical Info

Scott T. Tagawa, MD, MS, FACP is a Professor of Medicine and Urology at Weill Cornell Medicine, and an Attending Physician at NewYork-Presbyterian – Weill Cornell Medical Center.

After earning his BS from Georgetown University, Dr. Tagawa received his MD at the University of Southern California School of Medicine. After completing his Internship and Residency training there, he became Chief Resident and subsequently underwent fellowship training in Hematology and Medical Oncology, being appointed Chief Fellow for his final two years. He had the opportunity to train with international leaders in Genitourinary (GU) Oncology. In August 2005, he was appointed Assistant Professor of Medicine at Mount Sinai School of Medicine, serving as Associate Program Director for the Fellowship Training Program. As Director of Genitourinary Oncology for the Division of Hematology and Oncology and Director of Medical Oncology for the Deane Prostate Health and Research Center, Dr. Tagawa took the lead in developing genitourinary clinical trials. He was recruited to Weill Cornell Medical College in 2007. His research covers clinical and translational investigations in genitourinary tumors and thrombosis in malignancy. As the Medical Director of the Genitourinary Oncology Research Program, Dr. Tagawa leads clinical trials in the areas of prostate, kidney, and bladder cancer as well as the prevention and treatment of thrombosis with cancer. He specializes in drug development and theranostics in prostate cancer. Dr. Tagawa also serves as Associate Director of Clinical Research for the Division of Hematology and Medical Oncology, Medical Director of the Cancer Clinical Trials Office of the Meyer Cancer Center, and Chair of the Feasibility Committee for cancer clinical research. Dr. Tagawa is the WCMC principal investigator for the Alliance for Clinical Trials in Oncology (formerly CALGB), serving on the Board of Directors and as a funded member of the Genitourinary Committee. He is a member of the Clinical Practice Guidelines Committee of the American Society of Clinical Oncology (ASCO). Additionally, he serves on the editorial boards of many journals, is a member of numerous national and international medical and scientific societies, and has been named on multiple “top doctor” award lists.

A summary of Dr. Tagawa's Education, Training and/or Faculty Appointments is listed as following:

EDUCATION/TRAINING:

Georgetown University, Washington D.C. B.S.; 1993.

University of Southern California School of Medicine, Los Angeles, CA. M.D.; 1998.

Internship, Internal Medicine. University of Southern California Department of Medicine; June 1998 - June 1999.

Residency, Internal Medicine. University of Southern California Department of Medicine; July 1999 - June 2001.

Chief Resident, University of Southern California Department of Medicine, Los Angeles, CA.; July 2001 -June 2002.

Fellowship, Combined program in Hematology and Oncology. University of Southern California Department of Medicine, Divisions of Hematology and Oncology; July 2002 - June 2005.

Chief Fellow, Hematology; 2003-04.

Chief Fellow, Oncology; 2004-05.

Weill Cornell Graduate School of Medical Sciences, Masters of Science in Clinical Investigation; 2010.

ACADEMIC APPOINTMENTS:

Assistant Professor of Medicine, Division of Hematology & Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, NY; August 2005 - March 2007.

Director, Medical Oncology, Deane Prostate Health & Research Center, Mount Sinai Hospital; August 2005 - March 2007.

Director, Genitourinary Oncology, Division of Hematology & Oncology, Department of Medicine, Mount Sinai School of Medicine; January 2006 - March 2007.

Associate Director, Hematology/Oncology Fellowship Program, Mount Sinai School of Medicine, New York, NY; January 2006 - March 2007.

Assistant Professor of Medicine & Urology, Weill Cornell Medical College, New York, NY; 2007 - 2012.Medical Director, Genitourinary Oncology Research Program; July 2010 – Present.

Associate Professor of Clinical Medicine & Urology, Weill Cornell Medical College, New York, NY; 2013 - 2020.

Richard A Stratton Associate Professor in Hematology and Oncology; 2015 - 2020.

Professor of Medicine & Urology; 2020 - present

HOSPITAL APPOINTMENTS:

Attending Staff Physician, Los Angeles County University of Southern California Medical Center, Los Angeles, CA.; July 2001 - June, 2005.

Assistant Attending Staff Physician, Mount Sinai Medical Center, New York, NY; September 2005 -March 2007.

Assistant Attending Physician, NewYork-Presbyterian Hospital, New York, NY; April 2007 - 2012.

Associate Attending Physician, NewYork-Presbyterian Hospital, New York, NY; 2013 - 2020.

Attending Physician, NewYork-Presbyterian Hospital, New York, NY; 2020 - present

SOCIETY MEMBERSHIPS:

American Society of Clinical Oncology

American Society of Hematology

American College of Physicians

American Urologic Association

Alliance for Clinical Trials in Oncology (formerly CALGB)

American Association for Cancer Research

European Society for Medical Oncology

EDITORIAL BOARDS 

Urologic Oncology (Editor, Seminars Section)

Therapeutic Advances in Medical Oncology

Frontiers in Genitourinary Oncology

Annals of Oncology

Journal of Tumor

American Journal of Clinical and Experimental Urology

Ad hoc reviewer:

Journal of Urology

American Journal of Hematology

The Oncologist

Cancer Investigation

OncoTargets and Therapy

European Urology

Cancer

Clinical Cancer Research

International Journal of Cancer

Medical & Surgical Urology

Journal of Clinical Oncology

British Journal of Urology International

Advances in Urology

Lancet Oncology

ASCO-SEP (genitourinary section)

BMC Cancer

Lancet

JAMA Oncology

European Journal of Cancer

Honors and Awards

Deans List Scholar, Georgetown University College of Arts and Sciences Dean's List Scholar, 1989, 1992 

Mid-Atlantic Academic All Conference Water Polo, Georgetown University, 1993

Dean's Scholar for the Junior/Senior Continuum, University of Southern California School of Medicine, 1998

Intern of the Year, USC Department of Medicine, 1999

Junior Resident of the Year, USC Department of Medicine, 2000

Senior Resident of the Year, USC Department of Medicine, 2001

Brautbar Teaching Award, USC Department of Medicine, 2001

Teacher of the Year, Division of Hematology, USC Department of Medicine, 2004

Chiron Immunotherapy Research Fellowship Award, 2004-05

Young Investigator Award, Prostate Cancer Foundation, 2008-2011

Super Doctors New York 2009 - annually through present

America's Top Doctors For Cancer 2009 - annually through present

NIH Loan Repayment Program, Clinical Research (Extramural) 2009-2011

Top Doctors: New York Metro Area (13th Ed)

WCMC Department of Medicine Investigator Award Runner Up 2010

Guide to America’s Top Oncologists

Clinical Research, Loan Repayment Program Competitive Renewal, National Institutes of Health (Extramural)

America’s Top Doctors for Cancer, Volume 7

Top Doctors, US News & World Report 2011 

Top Doctors: New York Metro Area, 17th Ed.

America’s Top Physicians (Castle-Connolly)

2015: Newsweek Top Doctors

America's Top Doctors: 14th Edition, 13th Edition, 12th Edition, 11th Edition 

America's Top Doctors: 2017, 2016

Top Doctors New York Metro Area: 2010 - annually through present

America's Top Doctors for Cancer: 10th Edition, 9th Edition, 8th Edition, 7th Edition, 5th Edition

Top Doctors: New York Metro Area: 18th Edition, 17th Edition, 16th Edition, 15th Edition, 14th Edition, 13th Edition

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Hematology)
American Board of Internal Medicine (Medical Oncology)
Clinical Expertise
Prostate Cancer
Thrombosis
Bladder Cancer
Testicular Cancer
Kidney Cancer
Kidney or Bladder Cancer
Urologic Cancer
Immunotherapy
Languages
English
Education 
  • M.S.
    Weill Graduate School of Medical Sciences of Cornell University
    2010
  • M.D.
    University of Southern California School of Medicine
    1998
Appointments 
  • Attending Physician
    NewYork-Presbyterian Hospital
  • Professor of Medicine
    Weill Cornell Medical College, Cornell University
  • Professor of Medicine in Urology
    Weill Cornell Medical College, Cornell University
Videos

Prostate Cancer Clinical Trials NY | Weill Cornell Medicine Genitourinary Oncology Program

Kidney Cancer Treatment NY | Weill Cornell Medicine Genitourinary Oncology Program

Scott Tagawa, M.D., M.S.

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Consultant: 
AbbVie Inc.
AIkido Pharma Inc.
Ambrx, Inc.
Amgen, Inc.
Astellas Pharmaceuticals US, Inc.
Atlab Pharma SAS
Bayer Healthcare Pharmaceuticals
Blue Earth Diagnostics, Inc.
Clarity Pharmaceutical
Clovis Oncology, Inc.
Convergent Therapeutics, Inc
Daiichi Sankyo, Inc.
Dendreon Corporation
Eisai, Inc.
Endocyte, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
Immunomedics, Inc.
Janssen Biotech Inc.
Karyopharm Therapeutics, Inc.
Novartis Pharmaceuticals Corporation
Pfizer, Inc.
QED Therapeutics
Regeneron Pharmaceuticals, Inc.
Sanofi-Aventis
Seattle Genetics, Inc.
Telix Pharmaceuticals
Tolmar Pharmaceuticals, Inc.
Professional Services: 
Boston Scientific Corporation
Speaker/Lecturer: 
Amgen, Inc.
Dendreon Corporation
Ownership: 
AIkido Pharma Inc.
Convergent Therapeutics, Inc
Proprietary Interest: 
Gilead Sciences, Inc.
Other Interest: 
Merck
POINT Biopharma Inc.